Last 12 months
Inside the activity.
13 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 6 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2022 Filed Jun 9, 2022 10:04 UTC |
Agah RamtinDirector · Chief Medical Officer · 10% owner
|
GiftCommon Stock | 975,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-016226 · ownership.xml · nonDerivative · entry 1 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:45 UTC |
Macfarlane K. AngelaDirector
|
GrantStock option (right to buy) · Derivative | 4,582 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018488 · doc4.xml · derivative · entry 1 Macfarlane K. Angela · CIK 0001865182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 Underlying: Common Stock · 4,582 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:49 UTC |
Marton LaurenceDirector
|
GrantStock Option (right to buy) · Derivative | 4,582 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018494 · doc4.xml · derivative · entry 1 Marton Laurence · CIK 0001862192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 Underlying: Common Stock · 4,582 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:12 UTC |
Bagai ShaunDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 48,313 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018448 · doc4.xml · derivative · entry 1 Bagai Shaun · CIK 0001862613 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,313 Underlying: Common Stock · 48,313 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:24 UTC |
Agah RamtinDirector · Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,398 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018469 · doc4.xml · derivative · entry 1 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,398 Underlying: Common Stock · 21,398 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:41 UTC |
Diamond DavidDirector
|
GrantStock Option (right to buy) · Derivative | 9,165 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018483 · doc4.xml · derivative · entry 2 Diamond David · CIK 0001802807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,165 Underlying: Common Stock · 9,165 shares Expires 2032-03-10 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments beginning on September 26, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:41 UTC |
Diamond DavidDirector
|
GrantStock Option (right to buy) · Derivative | 4,582 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018483 · doc4.xml · derivative · entry 1 Diamond David · CIK 0001802807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 Underlying: Common Stock · 4,582 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:53 UTC |
RYAN UNA SDirector
|
GrantStock Option (right to buy) · Derivative | 4,582 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001209191-22-018500 · doc4.xml · derivative · entry 1 RYAN UNA S · CIK 0001255349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 Underlying: Common Stock · 4,582 shares Expires 2032-03-10 F1 · derivative.exercise_date: The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021. Read SEC document |
| March 03, 2022 Filed Jun 24, 2026 21:20 UTC |
RYAN UNA SDirector
|
OtherCommon Stock | 6,332 | $3.95 | $25,011.40 |
DisclosureSEC source: 0001493152-26-029958 · ownership.xml · nonDerivative · entry 2 RYAN UNA S · CIK 0001255349 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Una S. Ryan Revocable Trust Disclosed balance after: 54,121 F1 · kind: Reflects distribution from Astria Fund, of which the reporting person is a non-managing member. Read SEC document |
| March 03, 2022 Filed Jun 24, 2026 21:20 UTC |
RYAN UNA SDirector
|
OtherCommon Stock | 47,789 | $4.19 | $200,235.91 |
DisclosureSEC source: 0001493152-26-029958 · ownership.xml · nonDerivative · entry 1 RYAN UNA S · CIK 0001255349 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Una S. Ryan Revocable Trust Disclosed balance after: 47,789 F1 · kind: Reflects distribution from Astria Fund, of which the reporting person is a non-managing member. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:35 UTC |
Macfarlane K. AngelaDirector
|
GrantStock Option (right to buy) · Derivative | 11,154 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-21-059442 · doc4.xml · derivative · entry 1 Macfarlane Kirsten Angela · CIK 0001865182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,154 Underlying: Common Stock · 11,154 shares Expires 2031-10-01 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:42 UTC |
Marton LaurenceDirector
|
GrantStock Option (right to buy) · Derivative | 11,154 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-21-059466 · doc4.xml · derivative · entry 1 Marton Laurence · CIK 0001862192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,154 Underlying: Common Stock · 11,154 shares Expires 2031-10-01 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:23 UTC |
Diamond DavidDirector
|
GrantStock Option (right to buy) · Derivative | 11,154 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-21-059392 · doc4.xml · derivative · entry 2 Diamond David · CIK 0001802807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,461 Underlying: Common Stock · 11,154 shares Expires 2031-10-01 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:23 UTC |
Diamond DavidDirector
|
GrantStock Option (right to buy) · Derivative | 22,307 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-21-059392 · doc4.xml · derivative · entry 1 Diamond David · CIK 0001802807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,307 Underlying: Common Stock · 22,307 shares Expires 2031-10-01 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments beginning on September 26, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:46 UTC |
RYAN UNA SDirector
|
GrantStock Option (right to buy) · Derivative | 11,154 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001209191-21-059477 · doc4.xml · derivative · entry 1 RYAN UNA S · CIK 0001255349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,154 Underlying: Common Stock · 11,154 shares Expires 2031-10-01 F1 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2021. Read SEC document |
| September 30, 2021 Filed Oct 5, 2021 00:07 UTC |
Bagai ShaunDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 117,866 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001209191-21-059159 · doc4.xml · derivative · entry 1 Bagai Shaun · CIK 0001862613 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,866 Underlying: Common Stock · 117,866 shares Expires 2031-09-29 F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021. Read SEC document |
| September 30, 2021 Filed Oct 5, 2021 00:11 UTC |
Agah RamtinDirector · Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,203 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001209191-21-059161 · doc4.xml · derivative · entry 1 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,203 Underlying: Common Stock · 52,203 shares Expires 2031-09-29 F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021. Read SEC document |
| August 30, 2021 Filed Jun 17, 2022 20:06 UTC |
Agah RamtinDirector · Chief Medical Officer · 10% owner
|
ConversionWarrants (right to buy) · Derivative | 1,295 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001493152-22-017155 · ownership.xml · derivative · entry 3 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2026-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares of Common Stock underlying the warrant are immediately exercisable. Read SEC document |
| August 30, 2021 Filed Jun 17, 2022 20:06 UTC |
Agah RamtinDirector · Chief Medical Officer · 10% owner
|
ConversionConvertible Notes · Derivative | 1,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-017155 · ownership.xml · derivative · entry 2 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,295 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. Read SEC document |
| August 30, 2021 Filed Jun 17, 2022 20:06 UTC |
Agah RamtinDirector · Chief Medical Officer · 10% owner
|
ConversionCommon Stock | 1,295 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-017155 · ownership.xml · nonDerivative · entry 1 Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.